Pilot Study of Zonisamide in the Treatment of Essential Tremor

Loma Linda University0 个研究点目标入组 9 人2003年6月

适应症Essential Tremor

干预措施Zonisamide

概览

阶段: 不适用
干预措施: Zonisamide
疾病 / 适应症: Essential Tremor
发起方: Loma Linda University
入组人数: 9
主要终点: Tremor Severity
状态: 终止
最后更新: 11年前

概览研究者入排标准研究组 & 干预措施结局指标相似试验

概览

简要总结

The purpose of this study is to determine if Zonisamide is effective in reducing tremors in patients with Essential Tremor.

详细描述

The subjects will remain on their usual medication and a baseline assessment using the Fahn Tolosa Marin tremor rating scale will be performed and will be video taped.

注册库

clinicaltrials.gov

开始日期

2003年6月

结束日期

2012年12月

最后更新

11年前

研究类型

Interventional

研究设计

Single Group

性别

All

研究者

发起方

Loma Linda University

责任方

Sponsor

入排标准

入选标准

•Diagnosis of Essential Tremor based on the Tremor Investigational Group criteria for definite or probable Essential Tremor.
•Age: 18 years or over.
•Willingness and ability to comply with the study requirements and give informed consent.

排除标准

•Known history of psychiatric disorder, major depression, dementia, aplastic anemia, or Stevens-Johnson syndrome.
•Known alcohol or substance abuse in previous 12 months.
•Positive pregnancy test.
•Unwillingness to use adequate contraceptive methods if of childbearing potential.
•Known allergy to sulfonamides.
•Laboratory abnormalities prior to onset of trial.